Keratoconus (KC) is an eye disorder characterized by progressive thinning and changes in the cornea's shape. The cornea is the thin, transparent outer layer of the eye and usually is dome-shaped. Slowly progressive thinning of the cornea leads to a cone-shaped bulge to develop towards the cornea center in the most significant thinning areas. Affected people develop blurry or distorted vision, sensitivity to light (photophobia), and additional vision problems. Generally, KC is primarily diagnosed in young people at puberty or in their late teens. The exact cause of the disease is unknown. Several theories are based on research and its association with other conditions such as allergies and genetic causes; although no one theory explains it all, and a combination of things may cause it. Keratoconus Epidemiological Segmentation&nbsp;The Epidemiological Segmentation of Keratoconus in 7MM from 2017 to 2030 is segmented as:-&nbsp;<ul><li>Total Diagnosed Prevalent Population of Keratoconus</li><li>Severity-specific Distribution of Keratoconus</li><li>Age-specific distribution of Keratoconus</li></ul> <a href="https://www.delveinsight.com/report-store/keratoconus-epidemiology-forecast" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(0, 71, 178);">Keratoconus Epidemiology</a>&nbsp;<ul><li>The total diagnosed prevalent population of Keratoconus in 7MM in 2017 was 1,602,427</li><li>The diagnosed prevalent cases of Keratoconus in 2017 in the United States was 550,047&nbsp;</li><li>Keratoconus affects both males and females equally&nbsp;</li></ul> <a href="https://www.delveinsight.com/report-store/keratoconus-market" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(0, 71, 178);">Keratoconus Market</a>The market size of Keratoconus in 7MM in 2017 was USD 2,456 million&nbsp;&nbsp; Keratoconus Market Drivers<ul><li>The emergence of New Diagnostic Techniques</li><li>Increasing Awareness of KC</li><li>Genetic Factors</li><li>Environmental Factors</li></ul> Keratoconus Market Barriers<ul><li>Fewer patients available for clinical trials</li><li>Lack of variety in treatment options&nbsp;</li></ul> <a href="https://www.delveinsight.com/report-store/keratoconus-pipeline-insight" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(0, 71, 178);">Keratoconus Emerging Drugs</a>The emerging drugs of the Keratoconus market are&nbsp;<ul><li>IVMED-80</li></ul>And many others.&nbsp;&nbsp; Keratoconus Marketed TherapiesThe marketed therapies of the Keratoconus market are<ul><li>Photrexa Viscous and Photrexa</li><li>CE Marked Riboflavin Formulations</li><li>Ricrolin</li><li>Collagex Riboflavin</li><li>Peschke Riboflavin Solutions</li></ul>And many others.&nbsp;&nbsp; Keratoconus Key PlayersThe key players in the Keratoconus market are<ul><li>iVeena Delivery Systems</li><li>Glaukos/Avedro</li><li>Sooft Italia</li><li>Lightmed- OptiMed</li><li>Peschke Meditrade GmbH</li></ul>And many others. Stay tuned for latest updates on <a href="https://www.delveinsight.com/blog/keratoconus-market" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(0, 71, 178);">Keratoconus treatment market</a>

Keratoconus Market

Keratoconus Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.